Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 4, 1997

View Archived Issues

Sepracor's levalbuterol NDA accepted by FDA

ICOS and Abbott expand collaboration

Vertex and Alpha Therapeutic end hemoglobin collaboration

Anika completes phase III trial on Orthovisc

Activated Cell Therapy now named Dendreon Corporation

SmithKline Beecham and Incyte form diaDexus

Improved IOP-lowering prostaglandin analogues from Alcon

DuPont Merck discloses new anticoagulants

Large, long-term trial evaluates association between heart rate and mortality

Role of vitamin C in cardiovascular diseases investigated

Lipoprotein(a): new insights into the process of atherosclerosis

Subtype-selective NMDA receptor ligands reported

CV Therapeutics: Q2 1997 highlights

Celltech prepares PDE IV inhibitors

Vitronectin receptor antagonists described by Merck KGaA

Nippon Roche: products under development

DANAMI trial results presented

Texas Biotechnology: Q2 1997 highlights

Merck's asthma treatment receives first approvals

Genzyme General's Seprafilm receives approval in Japan

Neurobiological Technologies files IND for antiedema agent

AccuSite approved in Ireland and The Netherlands

Spotlight on adenosine A1 receptor agonists

DepoTech seeks Canadian approval for DepoCyt

Xoma: Q2 1997 highlights

NeuroSearch compound enters phase I for treatment of dementia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...